Product Code: ETC13287698 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Angina Pectoris Market was valued at USD 3.7 Billion in 2024 and is expected to reach USD 6.3 Billion by 2031, growing at a compound annual growth rate of 8.00% during the forecast period (2025-2031).
The Global Angina Pectoris Market is expected to witness steady growth in the coming years, driven by the rising prevalence of coronary artery disease and lifestyle factors contributing to heart-related issues. Key market players are focusing on developing innovative treatment options such as nitroglycerin, beta blockers, calcium channel blockers, and others to address the symptoms of angina pectoris. The market is also influenced by increasing healthcare expenditures, advancements in diagnostic technologies, and a growing elderly population susceptible to cardiovascular diseases. North America and Europe currently hold significant market shares due to well-established healthcare infrastructure and high awareness levels among the population. However, emerging economies in Asia-Pacific and Latin America are anticipated to witness rapid market growth due to improving healthcare access and increasing investments in healthcare infrastructure.
The Global Angina Pectoris Market is witnessing several key trends and opportunities. The increasing prevalence of lifestyle-related risk factors such as obesity, sedentary lifestyles, and unhealthy dietary habits is driving the demand for angina pectoris treatments. Advancements in medical technology, such as the development of innovative drug therapies and non-invasive procedures, are providing more effective and less invasive treatment options for patients. Additionally, the growing focus on personalized medicine and precision healthcare is opening up opportunities for tailored treatment approaches in angina pectoris management. Furthermore, the rising healthcare expenditure and improving healthcare infrastructure in emerging economies present a lucrative market for angina pectoris products and services. Overall, the market is poised for growth with a focus on improved patient outcomes and enhanced treatment options.
The Global Angina Pectoris Market faces several challenges, including the increasing prevalence of lifestyle-related risk factors such as obesity and sedentary lifestyles leading to a higher incidence of angina cases. Additionally, the availability of generic medications and the lack of significant innovation in treatment options pose challenges for market growth. Regulatory hurdles, stringent approval processes for new drugs, and the high cost of developing innovative therapies also hinder market expansion. Furthermore, the limited awareness about angina symptoms and treatment options among patients in developing regions, coupled with the stigma associated with cardiovascular diseases, present obstacles in effectively addressing and managing angina pectoris on a global scale. Overall, overcoming these challenges requires collaborative efforts from healthcare providers, pharmaceutical companies, and policymakers to improve access to quality care and innovative treatment solutions for angina patients worldwide.
The Global Angina Pectoris Market is primarily driven by factors such as the rising prevalence of cardiovascular diseases, including angina pectoris, due to lifestyle changes, unhealthy dietary habits, and increasing sedentary lifestyles. Additionally, the aging population worldwide is contributing to the growth of the market as the elderly are more susceptible to developing angina pectoris. Technological advancements in diagnostic tools and treatment options, along with increasing healthcare expenditure and awareness about heart health, are also driving market growth. Furthermore, the adoption of innovative treatment approaches, such as minimally invasive procedures and personalized medicine, is expected to fuel the market expansion in the coming years. Overall, the increasing burden of angina pectoris and the efforts to improve patient outcomes are key drivers shaping the Global Angina Pectoris Market.
Government policies related to the Global Angina Pectoris Market primarily focus on improving access to healthcare services, promoting research and development of innovative treatments, and ensuring drug safety and efficacy through regulatory oversight. Governments around the world have implemented measures to reduce healthcare disparities, enhance public awareness about angina pectoris, and support initiatives aimed at prevention and early detection of the disease. Additionally, regulatory agencies have established guidelines for the approval and monitoring of medications used to treat angina pectoris, with an emphasis on patient safety and quality of care. Overall, government policies in the Global Angina Pectoris Market aim to drive advancements in treatment options, improve patient outcomes, and address the economic burden of the disease on healthcare systems.
The Global Angina Pectoris Market is expected to exhibit steady growth in the coming years, driven by the increasing prevalence of cardiovascular diseases, sedentary lifestyles, and the aging population. Technological advancements in diagnostic tools and treatment options, such as drug therapies and surgical interventions, are also anticipated to contribute to market growth. Additionally, rising healthcare expenditure, improving healthcare infrastructure in developing countries, and growing awareness about the importance of early detection and management of angina pectoris are likely to further propel market expansion. However, challenges such as high treatment costs, stringent regulatory requirements, and the availability of alternative therapies may hinder market growth to some extent. Overall, the Global Angina Pectoris Market is forecasted to witness gradual but steady growth in the foreseeable future.
In the global angina pectoris market, North America holds a significant share due to the high prevalence of cardiovascular diseases and well-established healthcare infrastructure. Europe follows closely behind with a growing aging population and technological advancements in treatment options. Asia is emerging as a key market with increasing awareness about heart health and improving access to healthcare services. The Middle East and Africa region is witnessing a rise in cases of angina due to lifestyle changes and urbanization. Latin America is also showing potential for market growth with improving healthcare facilities and rising disposable income levels leading to better access to treatment options and medications for angina patients.
Global Angina Pectoris Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Angina Pectoris Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Angina Pectoris Market Revenues & Volume, 2021 & 2031F |
3.3 Global Angina Pectoris Market - Industry Life Cycle |
3.4 Global Angina Pectoris Market - Porter's Five Forces |
3.5 Global Angina Pectoris Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Angina Pectoris Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Global Angina Pectoris Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Global Angina Pectoris Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Angina Pectoris Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Angina Pectoris Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Angina Pectoris Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Angina Pectoris Market Trends |
6 Global Angina Pectoris Market, 2021 - 2031 |
6.1 Global Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Angina Pectoris Market, Revenues & Volume, By Nitrates, 2021 - 2031 |
6.1.3 Global Angina Pectoris Market, Revenues & Volume, By Beta Blockers, 2021 - 2031 |
6.1.4 Global Angina Pectoris Market, Revenues & Volume, By Calcium Channel Blockers, 2021 - 2031 |
6.2 Global Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Angina Pectoris Market, Revenues & Volume, By Stable Angina, 2021 - 2031 |
6.2.3 Global Angina Pectoris Market, Revenues & Volume, By Unstable Angina, 2021 - 2031 |
6.2.4 Global Angina Pectoris Market, Revenues & Volume, By Variant Angina, 2021 - 2031 |
6.3 Global Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Angina Pectoris Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Angina Pectoris Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.3.4 Global Angina Pectoris Market, Revenues & Volume, By Transdermal, 2021 - 2031 |
6.4 Global Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Angina Pectoris Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Angina Pectoris Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Angina Pectoris Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.5 Global Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Angina Pectoris Market, Revenues & Volume, By Direct Sales, 2021 - 2031 |
6.5.3 Global Angina Pectoris Market, Revenues & Volume, By Online Sales, 2021 - 2031 |
7 North America Angina Pectoris Market, Overview & Analysis |
7.1 North America Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
7.2 North America Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
7.5 North America Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Angina Pectoris Market, Overview & Analysis |
8.1 Latin America (LATAM) Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.4 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
8.5 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Angina Pectoris Market, Overview & Analysis |
9.1 Asia Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.4 Asia Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
9.5 Asia Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Angina Pectoris Market, Overview & Analysis |
10.1 Africa Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.4 Africa Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
10.5 Africa Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Angina Pectoris Market, Overview & Analysis |
11.1 Europe Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.4 Europe Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
11.5 Europe Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Angina Pectoris Market, Overview & Analysis |
12.1 Middle East Angina Pectoris Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Angina Pectoris Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Angina Pectoris Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Angina Pectoris Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.4 Middle East Angina Pectoris Market, Revenues & Volume, By Type, 2021 - 2031 |
12.5 Middle East Angina Pectoris Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Angina Pectoris Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Angina Pectoris Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Angina Pectoris Market Key Performance Indicators |
14 Global Angina Pectoris Market - Export/Import By Countries Assessment |
15 Global Angina Pectoris Market - Opportunity Assessment |
15.1 Global Angina Pectoris Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Angina Pectoris Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.3 Global Angina Pectoris Market Opportunity Assessment, By Type, 2021 & 2031F |
15.4 Global Angina Pectoris Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Angina Pectoris Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Angina Pectoris Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Angina Pectoris Market - Competitive Landscape |
16.1 Global Angina Pectoris Market Revenue Share, By Companies, 2024 |
16.2 Global Angina Pectoris Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |